Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4624151000168113 | Erlotinib (Cipla) (erlotinib 150 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4624161000168110 | Erlotinib (Cipla) 150 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erlotinib (Cipla) 150 mg tablet | Is a | Erlotinib (Cipla) | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 150 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 150 mg tablet | Is a | erlotinib 150 mg tablet | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 150 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 150 mg tablet | has intended active ingredient | erlotinib | true | Inferred relationship | Some | 1008272058 | |
| Erlotinib (Cipla) 150 mg tablet | has Australian BoSS | erlotinib | true | Inferred relationship | Some | 1008272058 | |
| Erlotinib (Cipla) 150 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1843743365 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erlotinib (Cipla) 150 mg tablet, 30, blister pack | has TPUU | True | Erlotinib (Cipla) 150 mg tablet | Inferred relationship | Some | 808021077 |
| Erlotinib (Cipla) 150 mg tablet, 30 | has TPUU | True | Erlotinib (Cipla) 150 mg tablet | Inferred relationship | Some | 818026153 |
Reference Sets
Australian dialect reference set
Trade product unit of use reference set
FHIR